JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $97 to $95.